Progress in monitoring blood safety

Transfusion

Volumn 50, Issue 7, 2010, Pages 1408-1412

  Holmberg, Jerry A ^a  

^a U S DEPARTMENT OF HEALTH AND HUMAN SERVICES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APHERESIS; BLOOD COMPONENT; BLOOD DONOR; BLOOD TRANSFUSION; EDITORIAL; HEPATITIS B; HUMAN; INCIDENCE; MONITORING; RISK ASSESSMENT; SCREENING TEST; UNITED STATES;

BIOLOGICAL MARKERS; BLOOD DONORS; BLOOD TRANSFUSION; DNA, VIRAL; HEPATITIS B; HEPATITIS C; HIV INFECTIONS; HUMANS; SAFETY;

EID: 77954343586     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2010.02728.x     Document Type: Editorial

References (21)

1. Zou S, Dorsey KA, Notari EP, Foster G, Krysztof D, Musavi F, Dodd RY, Stramer SL. Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing. Transfusion 2010 50 : 1495 504.
2. Zou S, Stramer S, Notari EP, Kuhns MC, Krystof D, Musavi F, Fang C, Dodd RY. Current incidence and residual risk of hepatitis B infection among blood donors in the United States. Transfusion 2009 49 : 1609 20.
3. Zou S, Musavi F, Norati EP, Stramer SL, Dodd RY. Prevalence, incidence, and residual risk of major blood-borne infections among apheresis collections to the American Red Cross Blood Services, 2004 through 2008. Transfusion 2010 50 : 1487 94.
4. Glynn SA, Schreiber GB, Busch MP, Kleinman SH, Williams AE, Nass CC, Ownby HE, Smith JW. Demographic characteristics, unreported risk behaviors, and the prevalence and incidence of viral infections: a comparison of apheresis and whole-blood donors. Transfusion 1998 38 : 350 8.
5. Saah AJ, Farzadegan H, Fox R, Nishanian P, Rinaldo CR Jr., Phair JP, Fahey JL, Lee TH, Polk BF. Detection of early antibodies in human immunodeficiency virus infection by enzyme-linked immunosorbent assay, Western blot, and radioimmunoprecipitation. J Clin Microbiol 1987 : 1605 10.
6. Surveillance for acute viral hepatitis - United States, 2007. MMWR 2009 58 : SS-3.
7. U.S. Food and Drug Administration. FDA'S Blood Products Advisory Committee Meeting. 94th Meeting.
8. McQuillan GM, Kruszon-Moran D, Granade T, Feldman JW. Seroprevalence of HIV in the US household population aged 18-49 years: the national health and nutrition examination surveys, 1999-2006. J Acquir Immune Defic Syndr 2010 53 : 117 23.
9. Shaz BH, Demmons DG, Hillyer KL, Jones RE, Hillyer CD. Racial differences in motivators and barriers to blood donation among blood donors. Arch Pathol Lab Med 2009 133 : 1444 7.
10. US Department of Health and Human Services. The 2007 National Blood Collection and Utilization Survey Report.
11. Eder AF, Benjamin RJ. TRALI risk reduction: donor and component management strategies. J Clin Apheresis 2009 24 : 122 9.
12. Commission Directive 2002/98/EC of the European Parliament and of the Council of 27 January 2003 setting standards of quality and safety for the collection, testing, processing, storage and distribution of human blood and blood components and amending Directive 2001/83/EC. Official J Eur Union 2003 L33/30 L33/40.
13. Commission Directive 2005/62/EC of 30 September 2005 implementing Directive 2002/98/EC of the European Parliament and of the Council as regards Community standards and specifications relating to a quality system for blood establishments. Official J Eur Union 2005 L 256/41.
14. Department of Health and Human Services. Biovigilance in the United States: efforts to bridge a critical gap in patient safety and donor health.
15. Busch MP, Glynn SA, Stramer SL, Strong M, Caglioti S, Wright DJ, Pappalardo B, Kleinman SK. A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors. Transfusion 2005 45 : 254 64.
16. Phelps R, Robbins K, Liberti T, Machuca A, Leparc G, Chamberland M, Kalish M, Hewlett I, Folks T, Lee LM, McKenna M. Window-period human immunodeficiency virus transmission to two recipients by an adolescent blood donor. Transfusion 2004 44 : 929 33.
17. Delwart EL, Kalmin ND, Jones TS, Ladd DJ, Foley B, Tobler LH, Tsui CP, Busch MP. First report of human immunodeficiency virus transmission via an RNA-screened blood donation. Vox Sang 2004 86 : 171 7.
18. U.S. Food and Drug Administration. Biological Product and HCT/P Deviation Reports - Annual Summary for Fiscal Year 2008.
19. Nübling CM, Heiden M, Chudy M, Kress J, Seitz R, Keller-Stanislawski B, Funk MB. Experience of mandatory nucleic acid test (NAT) screening across all blood organizations in Germany: NAT yield versus breakthrough transmissions. Transfusion 2009 49 : 1850 8.
20. AuBuchon JP, Whitaker BI. America finds hemovigilance! Transfusion 2007 47 : 1937 42.
21. Centers for Disease Control and Prevention. National healthcare safety network biovigilance component.